Company Analysis (Part 1)

Company Analysis

Company Profile:

Name of the company
Beximco Pharmaceuticals Limited
Year of Establishment
1976
Country of Incorporation
Bangladesh
Commercial Production
1980
Status
Public Limited Company
Business Lines
Manufacturing and marketing of pharmaceutical Finished Formulation products, Large Volume Parenterals and Active Pharmaceutical Ingredients (APIs).
Main Country of Operation
Bangladesh
Corporate Headquarter and Registered Address
17 Dhanmondi R/A, Road No. 2, Dhaka 1205, Bangladesh.
Phone: +880-2-8611891 (5 lines)
Fax: +880-2-8613470
Email: beximchq@bol-online.com
Operational Headquarters
19 Dhanmondi R/A, Road No. 7, Dhaka 1205, Bangladesh.
Phone: +880-2-8619151 (5 lines), +880-2-8619091 (5 lines)
Fax: +880-2-8613888
Email: info@bpl.net
Website: www.beximcopharma.com
Overseas Offices and Associates
Australia, Bhutan, Cambodia, Chile, Ghana, Hong Kong, Indonesia, Jordan, Kenya, Kuwait, Malaysia, Myanmar, Nepal, Pakistan, Philippines, Saudi Arabia, Singapore, Sri Lanka, Vietnam and Yemen.
Authorized Capital (Taka)
9100 million
Paid-Up Capital (Taka)
3,503.3 million
Number of Shareholders
Around 86000
Stock Exchange Listings
Dhaka and Chittagong Stock Exchanges of Bangladesh and AIM of
 London Stock Exchange.
Number of Employees
2,748
TIDM (Tradable Instrument Display Mnemonic)

BXP
Date shares were admitted to trading
Dhaka Stock Exchange: 3 July, 1985.
Chittagong Stock Exchange: 11 June, 1995.
AIM (Alternative Investment Market): 21 October, 2005.

ISIN
US0885792061

No comments:

Post a Comment